Our previous studies showed that HIPK2 binds, along with histone deacetylase 1 (HDAC1), to the HIF-1α gene promoter repressing the HIF-1-mediated transcription of many target genes including VEGF, therefore restraining tumor growth [28]. The gene discussed is HIF1A; the disease is neoplasm.